Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma

Por Dumaz, Nicolas
Publicado em 2011

The role of RICTOR downstream of receptor tyrosine kinase in cancers

Por Jebali, Ahlem, Dumaz, Nicolas
Publicado no Mol Cancer (2018)

Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms

Por Dumaz, Nicolas, Light, Yvonne, Marais, Richard
Publicado em 2002

Recent discoveries in the genetics of melanoma and their therapeutic implications

Por Marquette, Amélie, Bagot, Martine, Bensussan, Armand, Dumaz, Nicolas
Publicado em 2007

Atypical BRAF and NRAS Mutations in Mucosal Melanoma

Por Dumaz, Nicolas, Jouenne, Fanélie, Delyon, Julie, Mourah, Samia, Bensussan, Armand, Lebbé, Céleste
Publicado no Cancers (Basel) (2019)

Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations

Por Chraybi, Meriem, Alsamad, Issam Abd, Copie-Bergman, Christiane, Baia, Maryse, André, Jocelyne, Dumaz, Nicolas, Ortonne, Nicolas
Publicado em 2013

RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma

Por Laugier, Florence, Finet-Benyair, Adeline, André, Jocelyne, Rachakonda, P. Sivaramakrishna, Kumar, Rajiv, Bensussan, Armand, Dumaz, Nicolas
Publicado no Oncotarget (2015)

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation

Por Vallarelli, Andrelou F., Rachakonda, P. Sivaramakrishna, André, Jocelyne, Heidenreich, Barbara, Riffaud, Laurence, Bensussan, Armand, Kumar, Rajiv, Dumaz, Nicolas
Publicado no Oncotarget (2016)

Inhibition of the Proprotein Convertases Represses the Invasiveness of Human Primary Melanoma Cells with Altered p53, CDKN2A and N-Ras Genes

Por Lalou, Claude, Scamuffa, Nathalie, Mourah, Samia, Plassa, Francois, Podgorniak, Marie-Pierre, Soufir, Nadem, Dumaz, Nicolas, Calvo, Fabien, Basset-Seguin, Nicole, Khatib, Abdel-Majid
Publicado em 2010

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma

Por Tétu, Pauline, Delyon, Julie, André, Jocelyne, Reger de Moura, Coralie, Sabbah, Malak, Ghanem, Ghanem E, Battistella, Maxime, Mourah, Samia, Lebbé, Céleste, Dumaz, Nicolas
Publicado no Cancers (Basel) (2020)

Validation of a preclinical model for assessment of drug efficacy in melanoma

Por Delyon, Julie, Varna, Mariana, Feugeas, Jean-Paul, Sadoux, Aurélie, Yahiaoui, Saliha, Podgorniak, Marie-Pierre, Leclert, Geoffroy, Dorval, Sarra Mazouz, Dumaz, Nicolas, Janin, Anne, Mourah, Samia, Lebbé, Céleste
Publicado no Oncotarget (2016)

Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma

Por Julie, Delyon, Mariana, Varna, Feugeas, Jean-Paul, Sadoux, Aurélie, Yahiaoui, Saliha, Podgorniak, Marie-Pierre, Leclert, Geoffroy, Dorval, Sarra Mazouz, Dumaz, Nicolas, Janin, Anne, Mourah, Samia, Lebbé, Céleste
Publicado no Oncotarget (2016)

A Large French Case-Control Study Emphasizes the Role of Rare Mc1R Variants in Melanoma Risk

Por Hu, Hui-Han, Benfodda, Mériem, Dumaz, Nicolas, Gazal, Steven, Descamps, Vincent, Bourillon, Agnès, Basset-Seguin, Nicole, Riffault, Angélique, Ezzedine, Khaled, Bagot, Martine, Bensussan, Armand, Saiag, Philippe, Grandchamp, Bernard, Soufir, Nadem
Publicado em 2014

Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care

Por Louveau, Baptiste, Jouenne, Fanelie, Reger de Moura, Coralie, Sadoux, Aurelie, Baroudjian, Barouyr, Delyon, Julie, Herms, Florian, De Masson, Adele, Da Meda, Laetitia, Battistella, Maxime, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Publicado no Cancers (Basel) (2019)

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

Por Louveau, Baptiste, Delyon, Julie, De Moura, Coralie Reger, Battistella, Maxime, Jouenne, Fanelie, Golmard, Lisa, Sadoux, Aurelie, Podgorniak, Marie-Pierre, Chami, Ichrak, Marco, Oren, Caramel, Julie, Dalle, Stephane, Feugeas, Jean-Paul, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Publicado no Oncotarget (2019)

Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles

Por Eisenhardt, Anja E., Sprenger, Adrian, Röring, Michael, Herr, Ricarda, Weinberg, Florian, Köhler, Martin, Braun, Sandra, Orth, Joachim, Diedrich, Britta, Lanner, Ulrike, Tscherwinski, Natalja, Schuster, Simon, Dumaz, Nicolas, Schmidt, Enrico, Baumeister, Ralf, Schlosser, Andreas, Dengjel, Jörn, Brummer, Tilman
Publicado no Oncotarget (2016)